Compare Centrus Energy Corp (LEU) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centrus Energy Corp vs ResMed Inc. — how do they compare? Centrus Energy Corp trades at $191.59 (market cap $3.69B), while ResMed Inc. trades at $226.65 (market cap $32.78B). The key difference: ResMed Inc. is far larger — about 8.9× Centrus Energy Corp's market cap, and ResMed Inc. pays a 1.17% dividend while Centrus Energy Corp pays none. Which is the better fit depends on your goals.
| LEU | RMD | |
|---|---|---|
Market Cap | $3.69B | $32.78B |
Sector | Energy | Health |
52-Week High | $436.00 | $293.73 |
52-Week Low | $146.61 | $182.82 |
Enterprise Value | $3.00B | $32.14B |
Dividend Yield | — | 1.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Centrus Energy (LEU) trades at $185.06, down 2.18% on the day, with a bullish technical signal and key support at $183. The company reported Q2 2026 revenue of $176.1 million, beating estimates, and holds a $4.5 billion backlog, supported by a $900 million DOE award and a new HALEU supply agreement with X-energy (Seeking Alpha, August 13, 2026).
Outlook is positive due to strong government backing and nuclear fuel demand, but risks include margin compression from rising costs and execution challenges in scaling production. Analysts maintain a consensus price target of $228.50, with 42% buy ratings, indicating cautious optimism for growth driven by the nuclear renaissance.
ResMed (RMD) trades at $226.00, up 0.52% today, with a bullish technical signal from moving averages but a bearish oscillator reading. The company reported strong Q4 2026 earnings, beating EPS estimates with $2.95 versus $2.89 expected, and revenue growth of 9%. However, shares faced pressure due to weaker-than-expected fiscal 2027 revenue guidance. Fundamentals remain solid with a net income margin of 26.94% and robust cash flow from operations of $1.75 billion in 2025.
The outlook is mixed; strong profitability and consistent earnings beats support upside toward the $235.00 consensus price target, but near-term headwinds from guidance and cost pressures pose risks. Investment appeal hinges on execution against guidance and margin maintenance amid inflation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centrus Energy Corp
Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
